compound introduction
TTA-Q6 is a selective T-type Ca 2+ channel antagonist, which can be used in the research of neurological disease In Vitro TTA-Q6 is a selective T-type Ca 2+ channel antagonist, with 14 nM and 590 nM in FLIPR depolarized assaay and FLIPR hyperpolarized assay. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:T-type Ca 2+ channel
